PYY as an Obesity Drug: Potential, Challenges, and the Path to Clinical Development
PYY3-36 potently reduces appetite through Y2 receptor-mediated hypothalamic signaling, but clinical development faces challenges including nausea at therapeutic doses and limited duration of effect.
Quick Facts
What This Study Found
PYY3-36 reduces food intake through peripheral Y2 receptor-mediated hypothalamic appetite suppression, with clinical development challenges including dose-limiting nausea, route-dependent efficacy, and need for sustained-release formulations.
Key Numbers
How They Did This
review study on neuropeptides, weight-loss.
Why This Research Matters
Relevant for neuropeptides, weight-loss.
The Bigger Picture
Advances peptide/biomarker research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding PYY3-36 reduces food intake through peripheral Y2 receptor-mediated hypothalamic appetite suppression, with clinical development challenges including
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2005.
- Original Title:
- Peptide YY: a potential therapy for obesity.
- Published In:
- Current drug targets, 6(2), 171-9 (2005)
- Authors:
- Renshaw, D, Batterham, R L(2)
- Database ID:
- RPEP-01079
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
PYY as an Obesity Drug: Potential, Challenges, and the Path to Clinical Development
What was found?
PYY3-36 potently reduces appetite through Y2 receptor-mediated hypothalamic signaling, but clinical development faces challenges including nausea at therapeutic doses and limited duration of effect.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01079APA
Renshaw, D; Batterham, R L. (2005). Peptide YY: a potential therapy for obesity.. Current drug targets, 6(2), 171-9.
MLA
Renshaw, D, et al. "Peptide YY: a potential therapy for obesity.." Current drug targets, 2005.
RethinkPeptides
RethinkPeptides Research Database. "Peptide YY: a potential therapy for obesity." RPEP-01079. Retrieved from https://rethinkpeptides.com/research/renshaw-2005-peptide-yy-a-potential
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.